期刊文献+

非小细胞肺癌组织血管生成相关因子表达及临床病理分析

EXPRESSION OF RELATED FACTORS OF BLOOD VESSELS FORMATION IN NON SMALL CELL LUNG CANCER (NSCLC) AND CLINICAL PATHOLOGICAL ANALYSIS
下载PDF
导出
摘要 目的探讨血管内皮生长因子(VEGF)及其受体(Flt-1)、转化生长因子β1(TGF-β1)在非小细胞肺癌(non-smallcelllungcancer,NSCLC)组织血管形成中的意义及与肿瘤临床、生物学行为的关系。方法免疫组化染色观察VEGF、血管内皮生长因子受体-1(Flt-1)、TGF-β1在NSCLC组织中的表达,以CD34免疫组化染色来显示NSCLC组织中微血管生成情况和进行微血管密度判断。结果NSCLC组织中癌细胞不同程度地表达VEGF、血管内皮生长因子受体因子、TGF-β1,而对照组肺组织基本不表达(P<0·05);VEGF、Flt-1、TGF-β1阳性表达的NSCLC组织内微血管计数明显高于VEGF、Flt-1、TGF-β1表达阴性的NSCLC组织(P<0·05);NSCLC组织中VEGF、Flt-1、TGF-β1的阳性表达率和表达强度均与肿瘤淋巴结转移密切相关;随年龄增长,VEGF及其受体Flt-1的阳性表达率有所降低(P<0·05)。结论VEGF、Flt-1、TGF-β1的表达与NSCLC组织内肿瘤血管生成和淋巴结转移有密切关系,VEGF、Flt-1的表达与患者的年龄有一定关系。 Objective To investigate the significance of VEGF, Flt-1 and TGF-β1 in non small cell lung cancer (NSCLC). Methods The expressions of VEGF, Flt-1 and TGF-β1 were evaluated by S-P method, and the vascular endothelial cells were stained with anti-CD34 for observation and the mierovessel density count. Results The positive expression percentage of VEGF, Flt-1 and TGF-β1 in NSCLC groups was higher than that in control tissue (P〈0. 05). The intratumoral microvessel density in VEGF, Flt- 1 and TGF-β1positive groups was clearly higher than that in VEGF, Flt-1 and TGF-β1 negative groups (P〈0.05). The positive expression percentage and expression strength of VEGF, Flt-1 and TGF-β1 in NSCLC cases were related to lymph node metastasis (P〈0. 05). The positive expression percentage of VEGF and Flt-1 in NSCLC tissue was related to the age of the NSCLC patients. With aging, the positive expression percentage of VEGF and Flt-1 was decreased. Conclusion The expression of VEGF, Flt-1 and TGF-β1 was closely related to blood vessel formation and lymph node metastasis in NSCLC, and it may also be related to the age of the patients.
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2006年第6期679-684,共6页 Chinese Journal of Histochemistry and Cytochemistry
  • 相关文献

参考文献8

二级参考文献32

  • 1曹广文,杜平,杨文国,戚中田,孔宪涛.携带HuIFN-β cDNA的重组逆转录病毒载体的构建及在人肝癌细胞中的特异表达[J].第二军医大学学报,1996,17(4):301-305. 被引量:3
  • 2卢德宏,董彬,徐庆中.细胞增殖周期的调控及其抗调控因子抗体在肿瘤病理学研究中的应用[J].诊断病理学杂志,1996,3(1):61-62. 被引量:13
  • 3莫妮.肿瘤细胞生长初期的血管生成[J].国外医学情报,2000,(3):44-44.
  • 4Senger DR. Molecular framework for angiogenesis. Am J Pathol, 1996,149 :1.
  • 5Folkman J. Angiogenesis in cancer, vascular, rtaenmation and other disease.Nature Meal, 1995,1 : 27.
  • 6Soini Y, Kamel D, Paakko P, et al. Aberrant accumulation of P53 associates with Ki67 and mitotic count in benign skin lesions. Br J Dermatol, 1994,131:514.
  • 7Lababede O,Meziame MA,Rice TW. TNM staging of lung cancer: a quick reference chart. Chest, 1999,115:223.
  • 8Takahashi Y, Kitadai Y, Bucana CD, et al. Expression of vascular endothelia growth factor and its receptor. Cancer Res, 1995,55 : 3964.
  • 9Hideyuki Imoto MD, Toshiiro Osaki MD, Satoshi Taga MD, et al. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. Cell, 1997,79:452.
  • 10Jeremy PC, Tim O, Mike B, et al. Vascular endothelial growth factor is a predictor of replase and stage progression in superficial bladder cancer[J]. Cancer Res, 1997,57(5):5 281-5 285.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部